1-2 of 2
Natasha E. Lewis
Close
Sort by
Journal Articles

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Alison J. Moskowitz, Robert N. Stuver, Catherine R. Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E. Lewis, Andrew D. Zelenetz, M. Lia Palomba, Matthew J. Matasar, Ariela Noy, Audrey M. Hamilton, Paul Hamlin, Philip C. Caron, David J. Straus, Andrew M. Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N. Owens, Craig S. Sauter, Lorenzo Falchi, Jennifer K. Lue, Santosha A. Vardhana, Gilles Salles, Ahmet Dogan, Nikolaus D. Schultz, Maria E. Arcila, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5172–5186.
https://doi.org/10.1182/bloodadvances.2023009953
Published: 2023
Includes: Supplemental data
Journal Articles

Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms

Natasha E. Lewis, Kseniya Petrova-Drus, Sarah Huet, Zachary D. Epstein-Peterson, Qi Gao, Allison E. Sigler, Jeeyeon Baik, Neval Ozkaya, Alison J. Moskowitz, Anita Kumar, Steven M. Horwitz, Yanming Zhang, Maria E. Arcila, Ross L. Levine, Mikhail Roshal, Ahmet Dogan, Wenbin Xiao
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2261–2271.
https://doi.org/10.1182/bloodadvances.2020001636
Published: 2020
Includes: Supplemental data